PNB MetLife launches Mera Heart and Cancer Care Plan on World Cancer Day

PNB MetLife launches Mera Heart and Cancer Care Plan on World Cancer Day

MUMBAI, February 02, 2017: On the occasion of ‘World Cancer Day’ on February 4th, PNB MetLife, among India’s leading private life insurers, will launch Mera Heart and Cancer Care (MHCC) a non-linked and non-participating health insurance plan.

  • Comprehensive cover against all stages of cancer and heart diseases 
  • Special benefits for women 
  • Flexible payments mode 
  • Tax Benefits on premiums under Section 80D of Income Tax Act, 1961 
  • Log on to www.pnbmetlife.com for more information 

Mera Heart and Cancer Care is a tailor made product that provides comprehensive cover against all stages of cancer and heart diseases. The insurance plan along with its flexible and customized coverage offers special benefits for women with special premium rates. The customization in coverage comprises of payouts at different stages of the disease ranging from mild, moderate and severe, no survival period clause, additional monthly income option, waiver of premium, return of balance premium option on maturity, Life Cover and Terminal Illness cover to protect one’s family. 

Speaking on the launch, Khalid Ahmad, Head-Products, PNB MetLife said, “At PNB MetLife, we have always designed our products keeping in mind the diverse and changing needs of our customers. Our survey revealed that 61% of customers wanted a plan that will cover cancer plus heart. Additionally,  customers are looking for death benefits in such products. We have included these and many more key benefits in Mera Heart and Cancer Care, making this the first ever comprehensive, flexible product.” 


Key Features of Metlife Mera Heart and Cancer Care (MHCC): 

Customize your coverage 

  • Decide to cover yourself against Cancer, Heart or both diseases 
  • Get lump sum payouts during Mild, Moderate and Severe stages of the illness 
  • Get waiver of future premiums for next 5 policy years on first diagnosis of Mild or Moderate conditions 
  • Opt for additional monthly income (Platinum Plan) 
  • Choose to get your premiums back on maturity with ‘Return of Premium option’ 
  • Plan your coverage period - 10, 15 or 20 years 
  • Additionally, get Life Cover and Terminal Illness cover to protect your family. 


Special benefits for Women 

  • Female specific cancers covered, with special premium rates for women 


Tax benefits 

  • Avail tax benefits on premiums paid and benefits received, as per prevailing tax laws
Key benefits Gold Plan Platinum Plan
Heart Cover/ Cancer cover/ Hear and Cancer
Cover Mild stage Moderate Stage Severe Stage
25% of Sum insured
50% of Sum insured
100% of Sum insured
25% of Sum insured
50% of Sum insured
100% of Sum insured
Premium Waiver Benefit
Return of Balance Premiums
Monthly Income Benefit
Death/Terminal illness cover

Flexible premium payment modes & modal factors 

  • Elect to pay premiums by Yearly, Half Yearly, or Monthly mode subject to the minimum annualised premium under each mode.


High Sum Insured Discount

Sum Insured Intervals (Inclusive) Discount per Rs 1000 Sum Insured per annum
500000 - 1000000 Nil
1000001 - 1500000 Rs 0.5
1500001 - 2500000 Rs 1
Above 2500000 Rs 1.5

About PNB MetLife India Insurance Company Limited
PNB MetLife India Insurance Company Limited (PNB MetLife) has as its shareholders MetLife International Holdings LLC. (MIHL), Punjab National Bank Limited (PNB), Jammu & Kashmir Bank Limited (JKB), M. Pallonji and Company Private Limited and other private investors, with MIHL and PNB being the majority shareholders. 

For more information, follow us on twitter @PNBMetLife1, www.facebook.com/PNBMetLife or visit www.pnbmetlife.com

  • The marks “PNB” and “MetLife” are the registered trademarks of Punjab National Bank and Metropolitan Life Insurance Company, respectively. PNB MetLife India Insurance Company Limited is a licensed user of these marks”.
  • For more details on risk factors, terms and conditions, please read the sales brochure carefully before concluding the sale.